1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United Kingdom >
  5. Molecular Devices Acquires Cellesce

M&A Deal Summary

Molecular Devices Acquires Cellesce

On December 6, 2022, Molecular Devices acquired life science company Cellesce

Acquisition Highlights
  • This is Molecular Devices’ 1st transaction in the Life Science sector.
  • This is Molecular Devices’ 1st transaction in the United Kingdom.

M&A Deal Summary
Date 2022-12-06
Target Cellesce
Sector Life Science
Buyer(s) Molecular Devices
Deal Type Add-on Acquisition

Target

Cellesce

Cardiff, United Kingdom
Cellesce is a biotechnology company that specializes in contract development and manufacturing of large scale patient-derived organoids (PDOs) for diverse applications, including drug screening. Cellesce is based in Cardiff, United Kingdom.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Molecular Devices

Sunnyvale, California, United States
Category Company
Founded 1983
Sector Life Science
Employees631
DESCRIPTION

Molecular Devices LLC provides bioanalytical instruments, software, and assay kits for drug discovery & drug development, life science research, and bioassay/test development. Our global headquarters are located in the Silicon Valley area of Northern California. We also have a number of offices throughout the world.

DEAL STATS #
Overall 3 of 3
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 3 of 3
Country: United Kingdom M&A 1 of 1
Year: 2022 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2006-09-07 Applied Imaging

San Jose, California, United States

Applied Imaging Corp., a supplier of automated imaging and image analysis systems.

Buy $18M
Mergr

Solution for

Product

Company

Legal